丘脑底核电刺激治疗VPS16相关肌张力障碍的多中心研究
该国际多中心观察性研究纳入26例携致病性VPS16变异且药物难治的肌张力障碍患者,评估脑深部电刺激(DBS)的疗效。末次随访时(平均102.5个月),BFMDRS-M平均改善41.6%,BFMDRS-D平均改善34.8%,73%患者为应答者。刺激苍白球内侧部后腹侧与更佳运动改善相关,术前痉挛和固定骨骼畸形与改善呈负相关。
要点
- DBS对约四分之三的VPS16相关肌张力障碍患者有效。
- 运动改善在术后1年最明显,末次随访仍持续存在。
- 术前痉挛和固定骨骼畸形与较差运动改善相关。
核心结论
- DBS是该队列中四分之三携致病性VPS16变异肌张力障碍患者的有效治疗。
- 平均运动改善在1年随访时最明显,但末次随访时仍持续存在,尽管疾病进展。
研究设计与样本
- 国际多中心观察性研究,收集10个中心26例植入DBS的药物难治性DYT-VPS16患者的术前和术后人口学、临床、刺激、遗传、神经影像和神经生理数据。
主要发现
- 末次随访平均102.5±57.3个月(范围2-216个月),26例患者BFMDRS-M平均改善41.6±37.3%,23例患者BFMDRS-D平均改善34.8±42.6%。
- 19/26例(73%)患者被认为是应答者。
- 苍白球内侧部后腹侧刺激与更高的运动改善相关。
- 末次随访BFMDRS-M改善与术前痉挛(p=0.027)和固定骨骼畸形(p=0.001)呈显著负相关。
- 无应答者发病年龄和植入年龄更小、DBS手术时病程更短、基线BFMDRS评分更高。
关键数值与推荐
- DBS应答的截断阈值设定为末次随访时BFMDRS-M较基线改善25%。
临床怎么用
- 对于药物难治的VPS16相关肌张力障碍,DBS可作为有效治疗选择,尤其应关注苍白球内侧部后腹侧靶点。
- 术前存在痉挛或固定骨骼畸形可能提示DBS运动改善有限,需在术前评估中加以考虑。
局限性
- 本研究为观察性研究,样本量26例,未设对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to evaluate the effects of deep brain stimulation (DBS) in an international cohort of patients with VPS16-related dystonia. METHODS: This observational study collected preoperative and postoperative demographic, clinical, stimulation, genetic, neuroimaging, and neurophysiological data of medically refractory DYT-VPS16 patients with implanted DBS in 10 international centers. Motor symptoms and disability outcomes were assessed using the Burke-Fahn-Marsden Dystonia Rating Scale Motor (BFMDRS-M) and Disability (BFMDRS-D) scales. A cut-off threshold for considering response to DBS was set at 25% of BFMDRS-M improvement at the last follow-up (FU) compared to baseline. RESULTS: The cohort consisted of 26 participants (17 men, 65.4%). Age at dystonia onset and surgery was 17.8 ± 10.9 and 35.3 ± 14.8 years, respectively. At the last FU, 102.5 ± 57.3 months (range, 2-216), the mean BFMDRS-M improvement was 41.6 ± 37.3% (26/26 patients) and 34.8 ± 42.6% for the BFMDRS-D (23/26 patients). Most patients (19/26, 73%) were considered responders. Higher motor improvement was associated with stimulation of the ventroposterior portion of the internal globus pallidus. A significant inverse relationship was observed between improvement in BFMDRS-M at last FU, and the presence of spasticity (p = 0.027) and fixed skeletal deformities (p = 0.001) before surgery. Non-responders had a younger age at disease onset and at implantation, shorter disease duration at DBS surgery, and higher baseline BFMDRS scores. INTERPRETATION: DBS was an effective treatment for three-quarters of patients with pathogenic VPS16 variants in our cohort. Mean motor improvement was most pronounced at the 1-year FU, but persisted at the last FU despite disease progression. ANN NEUROL 2025;98:711-725.
引用
- Svorenova T, Romito LM, Kaymak A, et al. Deep Brain Stimulation for VPS16-Related Dystonia: A Multicenter Study. Ann Neurol. 2025. PMID: 40539388. doi:10.1002/ana.27290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。